<< Chapter < Page | Chapter >> Page > |
Niclosamide is a synthetic drug that has been used for over 50 years to treat tapeworm infections. Although its mode of action is not entirely clear, niclosamide appears to inhibit ATP formation under anaerobic conditions and inhibit oxidative phosphorylation in the mitochondria of its target pathogens. Niclosamide is not absorbed from the gastrointestinal tract, thus it can achieve high localized intestinal concentrations in patients. Recently, it has been shown to also have antibacterial, antiviral, and antitumor activities. J.-X. Pan et al. “Niclosamide, An Old Antihelminthic Agent, Demonstrates Antitumor Activity by Blocking Multiple Signaling Pathways of Cancer Stem Cells.” Chinese Journal of Cancer 31 no. 4 (2012):178–184. F. Imperi et al. “New Life for an Old Drug: The Anthelmintic Drug Niclosamide Inhibits Pseudomonas aeruginosa Quorum Sensing.” Antimicrobial Agents and Chemotherapy 57 no. 2 (2013):996-1005. A. Jurgeit et al. “Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects.” PLoS Pathogens 8 no. 10 (2012):e1002976.
Another synthetic antihelminthic drug is praziquantel , which used for the treatment of parasitic tapeworms and liver flukes , and is particularly useful for the treatment of schistosomiasis (caused by blood flukes from three genera of Schistosoma ). Its mode of action remains unclear, but it appears to cause the influx of calcium into the worm, resulting in intense spasm and paralysis of the worm. It is often used as a preferred alternative to niclosamide in the treatment of tapeworms when gastrointestinal discomfort limits niclosamide use.
The thioxanthenones , another class of synthetic drugs structurally related to quinine , exhibit antischistosomal activity by inhibiting RNA synthesis. The thioxanthenone lucanthone and its metabolite hycanthone were the first used clinically, but serious neurological, gastrointestinal, cardiovascular, and hepatic side effects led to their discontinuation. Oxamniquine, a less toxic derivative of hycanthone, is only effective against S. mansoni , one of the three species known to cause schistosomiasis in humans. Praziquantel was developed to target the other two schistosome species, but concerns about increasing resistance have renewed interest in developing additional derivatives of oxamniquine to target all three clinically important schistosome species.
Common Antihelminthic Drugs | |||
---|---|---|---|
Mechanism of Action | Drug Class | Specific Drugs | Clinical Uses |
Inhibit microtubule formation, reducing glucose uptake | Benzimidazoles | Mebendazole, albendazole | Variety of helminth infections |
Block neuronal transmission, causing paralysis and starvation | Avermectins | Ivermectin | Roundworm diseases, including river blindness and strongyloidiasis, and treatment of parasitic insects |
Inhibit ATP production | Not applicable | Niclosamide | Intestinal tapeworm infections |
Induce calcium influx | Not applicable | Praziquantel | Schistosomiasis (blood flukes) |
Inhibit RNA synthesis | Thioxanthenones | Lucanthone, hycanthone, oxamniquine | Schistosomiasis (blood flukes) |
Notification Switch
Would you like to follow the 'Microbiology' conversation and receive update notifications?